Intervention for Fatigue in HCT Recipients

Completed · Not applicable

Conditions studied: Hematologic Cancer, Hematologic Malignancy

In brief

The purpose of this study is to assess whether a cognitive-behavioral therapy (CBT) for fatigue intervention is acceptable, feasible, and effective at managing fatigue and improving quality of life for patients following hematopoietic stem cell transplant (HCT).

Key facts

Study ID

NCT05715047

Run by

Massachusetts General Hospital

People needed

66

Starts

2023-11-29

Expected to finish

2025-10-27

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adult patients (≥ 18 years)
• have the ability to speak and read English
• have undergone autologous or allogeneic transplant > 6 months prior to enrollment
• no evidence of disease relapse requiring therapy
• no new other malignancy requiring therapy after transplant
• report moderate to severe fatigue in the past week (FSI average severity item rating ≥ 4 of 0-10)
• are currently receiving their care at the MGH Blood and Marrow Transplant Clinic

You may not qualify if…

• Patients with active cognitive impairment or uncontrolled psychiatric illness such as schizophrenia that the treating clinician believes prohibits informed consent or participation in the intervention
• Patients already receiving CBT care
• Patients living with untreated sleep apnea
• Patients with hypoxemia requiring oxygen supplementation

Where it is running

• Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.